Lite Strategy (LITS) Revenue (2016 - 2023)
Lite Strategy (LITS) posted Revenue of $65.3 million for Q3 2023, up 4381.61% on a QoQ basis from $1.5 million in Q2 2023, and up 647.96% year-over-year from $8.7 million in Q3 2022.
Analysis
Lite Strategy (LITS) Revenue (2016 - 2023) Analysis & Trends
Lite Strategy has reported Revenue for 8 years, with the latest figure at $65.3 million in Q3 2023.
- On a quarterly basis, Revenue rose 647.96% year-over-year to $65.3 million in Q3 2023; TTM through Jun 2024 was $65.3 million, a 33.76% increase from a year earlier, with the FY2024 full-year figure at $65.3 million, up 33.76% from the prior year.
- Revenue was $65.3 million for Q3 2023 at Lite Strategy, up from $1.5 million in the prior quarter.
- The five-year high for Revenue was $65.3 million in Q3 2023, with the low at $1.0 million in Q4 2019.
- Average Revenue over 5 years is $11.6 million, with a median of $7.8 million recorded in 2021.
- The sharpest annual moves came in 2020 and 2023: Revenue soared 2158.99% in 2020, then plunged 87.23% in 2023.
- Over 5 years, Revenue stood at $1.0 million in 2019, then soared by 1149.5% to $12.6 million in 2020, then fell by 6.06% to $11.8 million in 2021, then soared by 176.66% to $32.7 million in 2022, then jumped by 99.47% to $65.3 million in 2023.
- The last three Revenue figures came in at $65.3 million (Q3 2023), $1.5 million (Q2 2023), and $5.9 million (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 65.30 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 5.89 Mn |
| Dec 31, 2022 | 32.74 Mn |
| Sep 30, 2022 | 8.73 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Mar 31, 2022 | 9.69 Mn |
| Dec 31, 2021 | 11.83 Mn |
| Sep 30, 2021 | 7.76 Mn |
| Jun 30, 2021 | 7.45 Mn |
| Mar 31, 2021 | 8.11 Mn |
| Dec 31, 2020 | 12.60 Mn |
| Sep 30, 2020 | 6.64 Mn |
| Jun 30, 2020 | 25.50 Mn |
| Mar 31, 2020 | 1.24 Mn |
| Dec 31, 2019 | 1.01 Mn |
| Sep 30, 2019 | 1.16 Mn |
| Jun 30, 2019 | 1.13 Mn |
| Mar 31, 2019 | 1.25 Mn |
| Dec 31, 2018 | 2.05 Mn |